Bubbled RNA-Based Cargo for Boosting RNA Interference

被引:29
|
作者
Kim, Hyejin [1 ]
Jeong, Jaepil [1 ]
Kim, Dajeong [1 ]
Kwak, Gijung [2 ,3 ]
Kim, Sun Hwa [3 ]
Lee, Jong Bum [1 ]
机构
[1] Univ Seoul, Dept Chem Engn, 163 Seoulsiripdaero, Seoul 02504, South Korea
[2] Korea Univ, KIST Grad Sch Converging Sci & Technol, 145 Anam Ro, Seoul 02841, South Korea
[3] KIST, Biomed Res Inst, Ctr Theragnosis, Seoul 02792, South Korea
来源
ADVANCED SCIENCE | 2017年 / 4卷 / 08期
基金
新加坡国家研究基金会;
关键词
SIRNA DELIVERY; DNA; NANOPARTICLES; NANOTECHNOLOGY; TRANSCRIPTION; OLIGONUCLEOTIDES; MICROSPONGES; THERAPEUTICS; CHALLENGES; GENERATION;
D O I
10.1002/advs.201600523
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As ribonucleic acid (RNA) nanotechnology has advanced, it has been applied widely in RNA-based therapeutics. Among the range of approaches, enzymatically synthesized RNA structures for inducing RNA interference in cancer cells have potential for silencing genes in a target-specific manner. On the other hand, the efficiency of gene silencing needs to be improved to utilize the RNA-based system for RNAi therapeutics. This paper introduces a new approach for efficient generation of siRNA from bubbled RNA-based cargo (BRC). The presence of bubbles in between to avoid nonfunctional short dsRNAs allows the RNA-based cargoes to contain multiple Dicer-cleavage sites to release the functional siRNAs when introduced to cells. BRCs can be synthesized easily in a one-pot process and be purified by simple centrifugation. Furthermore, efficient target gene silencing by the bubbled structure is confirmed both in vitro and in vivo. Therefore, this bubbled RNA cargo system can be utilized for target-specific RNAi therapeutics with high efficiency in the generation of functional siRNAs in the target cells.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] RNA-based drugs: From RNA interference to short interfering RNAs
    Poliseno, L
    Mercatanti, A
    Citti, L
    Rainaldi, G
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (04) : 361 - 368
  • [2] RNA interference in vivo:: Toward synthetic small inhibitory RNA-based therapeutics
    De Fougerolles, A
    Manoharan, M
    Meyers, R
    Vornlocher, HP
    RNA INTERFERENCE, 2005, 392 : 278 - 296
  • [3] Shortcomings of short hairpin RNA-based transgenic RNA interference in mouse oocytes
    Sarnova, Lenka
    Malik, Radek
    Sedlacek, Radislav
    Svoboda, Petr
    JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, 2010, 9
  • [4] Fluorogenic RNA-based biomaterials for imaging and tracking the cargo of extracellular vesicles
    Bonacquisti, Emily E.
    Ferguson, Scott W.
    Wadsworth, Gable M.
    Jasiewicz, Natalie E.
    Wang, Jinli
    Chaudhari, Ameya P.
    Kussatz, Caden C.
    Nogueira, Ana T.
    Keeley, Daniel P.
    Itano, Michelle S.
    Bolton, Matthew L.
    Hahn, Klaus M.
    Banerjee, Priya R.
    Nguyen, Juliane
    JOURNAL OF CONTROLLED RELEASE, 2024, 374 : 349 - 368
  • [5] RNA-based therapies
    不详
    NATURE BIOTECHNOLOGY, 2019, 37 (02) : 129 - 129
  • [6] RNA-based therapies
    Nature Biotechnology, 2023, 41 : 1071 - 1071
  • [7] RNA-based therapies
    不详
    NATURE BIOTECHNOLOGY, 2023, 41 (08) : 1071 - 1071
  • [8] RNA-based therapies
    Irena Melnikova
    Nature Reviews Drug Discovery, 2007, 6 : 863 - 864
  • [9] RNA-based therapies
    Nature Biotechnology, 2019, 37 : 129 - 129
  • [10] RNA-based reprogramming
    Baker, Monya
    NATURE METHODS, 2011, 8 (01) : 18 - 18